AG 013736 - Axitinib

Based on 12 reference(s) in Google Scholar 9 10 12

Axon 1414

CAS [319460-85-0]

MF C22H18N4OS
MW 386.47

  • Purity: 99%
  • Soluble in DMSO

AG 013736

Description

A tyrosine kinase inhibitor (TKI), targeting VEGFR/PDGFR/c-KIT; orally bioavailable drug exerting an anti-angiogenic effect.

KEYWORDS: AG 013736 | supplier | VEGFR inhibitor | Axitinib | AG013736 | AG-013736 | AG-13736 | CAS [319460-85-0] | SCF | PDGF | VEGF | c-KIT | PDGFR | VEGFR | Tyrosine kinase inhibitor | TKI | RTK | orally bioavailable | anti-angiogenic

Order
Size Unit Price Stock
5 mg €75.00 In Stock
25 mg €225.00 In Stock
Special Offers
Size Unit Price Stock
2 x 5 mg €100.00 In Stock
2 x 25 mg €300.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...